Clinical Trials

Showing trials with last updates posted in 2021.

NCT03462212 | UNKNOWN | PHASE1/PHASE2
290 participants

Carboplatin-Paclitaxel-Bevacizumab vs Carbo-Pacli-Beva-Rucaparib vs Carbo-Pacli-Ruca, Selected According to HRD Status, in Patients With Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer, Preceded by a Phase I Dose Escalation Study on Ruca-Beva Combination

Study Type:
INTERVENTIONAL
Last Updated:
2021-08-27
Start Date:
2021-03-17
Completion:
2025-03-01
Conditions
  • Advanced (Stage IIIB-C-IV) Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Interventions
  • DRUG
No Results Yet
NCT03387020 | COMPLETED | PHASE1
22 participants

Ribociclib and Everolimus in Treating Children With Recurrent or Refractory Malignant Brain Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2021-08-27
Start Date:
2018-01-13
Completion:
2020-04-01
Conditions
  • CNS Embryonal Tumor, Not Otherwise Specified
  • Malignant Glioma
  • Recurrent Atypical Teratoid/Rhabdoid Tumor
  • Recurrent Childhood Ependymoma
  • Recurrent Diffuse Intrinsic Pontine Glioma
  • Recurrent Medulloblastoma
  • Refractory Diffuse Intrinsic Pontine Glioma
Interventions
  • DRUG
  • OTHER
NCT03254875 | COMPLETED | NA
309 participants

Rehabilitation After Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2021-08-27
Start Date:
2017-08-15
Completion:
2021-03-31
Conditions
  • Breast Cancer
Interventions
  • BEHAVIORAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page